Compositions and methods for the treatment of cancer using recom

Details Compositions and methods for the treatment of cancer using recom Compositions and methods for the treatment of cancer using recom

1996-01-08

1998-08-04

Chambers, Jasemine C.

Chemistry: molecular biology and microbiology

Vector, per se

514 44, 514696, C12N 1500, A61K 4800, A01N 3502

Patent

active

057892440

ABSTRACT:
A method and pharmaceutical composition for the treatment of cancer using a gene delivery system, such as a viral vector delivery system, comprising a therapeutic gene wherein the gene delivery system is formulated in a buffer comprising a delivery-enhancing agent such as ethanol.

REFERENCES:
patent: 5552309 (1996-09-01), March
Greenberg, R. et al., "Intraversical AD 32 (N-Trifluoroacetyladriamycin-14-Valerate) in the Treatment of Patients with Refractory Bladder Carcinoma-Clinical Efficacy, Pharmacology, and Safety," Proc. Amer. Urological Assoc.153 Supp 233A:19 (1995).
Abe et al., Transduction of a Drug-Sensitive Toxic Gene into Human Leukemia Cell Lines with a Novel Retroviral Vector (43611), Proc. Soc. Exp. Biol. Med., 2003:354-359 (1993).
Banerjee et al., "Changes in Growth and Tumorigenicity Following Reconstitution of Retinoblastoma Gene Function in Various Human Cancer Cell types by Microcell Transfer of Chromosome 13," Cancer Research, 52:6297-6304 (1992).
Bass et al., "Recombinant Adenovirus-Mediated Gene Transfer to Genitourinary Epithelium In Vitro and In Vivo," Cancer Gene Therapy, 2(2):97-104 (1995).
Blixt et al., "Enhancement of Intracellular Uncoating of Adenovirus in HeLa cells in the Presence of Benzyl Alcohol as a Membrane Fluidizer," Arch Virol, 1299:265-277 (1993).
Brewster et al., Eur. Urol., 25:177-182 (1994).
Cairns et al., "Loss of Heterozygosity at the RB Locus is Frequent and Correlates with Muscle Invasion in Bladder Carcinoma," Oncogene, 6:2305-2309 (1991).
Cancer Facts and Figures, 5-11 (1995).
Fujimoto et al., "Frequent Association of p53 Gene Mutation in invasive Bladder Cancer," Cancer Research, 52:1393-1398 (1992).
Good et al., Biochemistry, 5:467 (1966).
Goodrich et al., "Expression of the Retinoblastoma Gene Product in Bladder Carcinoma Cell Associates with a Low Frequency of Tumor Formation," Cancer Research, 52:1968-1973 (1992).
Li et al., Human Gene Therapy, 4:403-409 (1993).
Monson et al., "Indigocarmine as a Quantitative Indicator of Urothelial Integrity," The Journal of Urology, 145:842-845 (1992).
Morris et al., "Adenoviral-Mediated Gene Transfer to Bladder In Vivo," J. Urology, 152:506-509 (1994).
Parsons et al., "Bladder Surface Gycosaminoglycans: An Epithelial Permeability Barrier," J. Urol., 143:139-142 (1990).
Rosenberg, Steven A., "The Immunotherapy and Gene Therapy of Cancer," Journal of Clinical Oncology, 10(2):180-100 (1992).
Spandidos et al., "Expression of the Normal H-ras1 Gene Can Suppress the Transformed and Tumorigenic Phenotypes Induced by Mutant ras Genes," Anticancer Research, 10:1543-1554 (1990).
Takahashi et al., "The Retinoblastoma Gene Functions As a Growth and Tumor Suppressor in Human Bladder Carcinoma Cells," Proc. Natl. Acad. Sci. USA, 88:5257-5261 (1991).
Wills et al., "Development and Characterization of Recombinant Adenoviruses Encoding Human p53 for Gene Therapy of Cancer," Human Gene Therapy, 5:1079-1088 (1994).

Affiliated with

Also associated with

Rating

Compositions and methods for the treatment of cancer using recom does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for the treatment of cancer using recom, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for the treatment of cancer using recom will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1176179